Akston Biosciences leverages its AmbifectTM Fc-fusion protein platform to develop and manufacture new classes of biologics. Akston owns and operates a GMP biologics cleanroom facility that manufactures kilogram-scale batches of drug substance for itself and customers. This, along with its research and process development laboratories, are located in Beverly, MA.
